blinqbanner.png
 
There is something terribly wrong with the status quo when half of the children with amblyopia go undetected and untreated before school age
— David G Hunter
 
 
blinq w circle.png
 
 
 
 
 

Direct detection of micro-strabismus and amblyopia (lazy eye) is now possible!

blinq (pediatric vision scanner) is the first instrument designed for vision screening programs that actually detects micro-strabismus and amblyopia. Using a novel new technology, blinq conducts a 2-second Neural Performance Scan of the fovea to accurately detect binocularity associated with as little as 1-degree misalignment. 

 
 
 

What is a Neural Performance Scan?

Using proprietary retinal polarization scanning to measure bilateral fixation via fibers of the fovea, NPS precisely measures retinal nerve fiber patterns, instantly determining if fault fixation is present. NPS is cleared by the FDA for screening of micro-strabismus and amblyopia (lazy eye).

 
NeuralPerformanceScanning.png
 
 
 
 

“Vision screening is strongly recommended by the American Academy of Pediatrics over the course of childhood to detect amblyopia to allow successful treatment”

-AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS

 
 
HandOverOneEye.Smiling.jpg

 

 
 
NIH:NEIResults copy 2.png

Why is direct detection
so important?

Clinical studies funded by the NIH/NEI have shown that screening with Rebion's blinq technology is a dramatically more accurate approach to measuring for amblyopia than methods which merely collect data on amblyopia risk factors (ARF).* Greater accuracy leads to a reduction in care costs while improving patient outcomes.

*JAMA Ophthamol. 2014;132(7):814-820.doi:10.1001/jamaophthalmol.2014.424. Published online May 29, 2014.

 
 
 

Amblyopia represents a syndrome of compromised deficits:

  • Micro Strabismus

  • Strabismus

  • Refractive Error

  • Decreased Depth Perception (Stereopsis)

  • Reduced Visual Acuity (20/40 or Greater Corrected)

 
strabismusgraphic3.png
 
 
 
 

“The Pediatric Vision Scanner provides a novel method of screening directly for amblyopia, rather than for its risk factors.”

JONATHAN M. HOLMES, BM, BCH COMMENTARY FOR JAMA JULY 2014

 

 
Optic-nerve.jpg

 

Why choose blinq?

 
 
 
passassurance-01.png

Unprecedented Accuracy

blinq is a new technology that can empower vision screening staff to detect amblyopia and strabismus in preschool children with high sensitivity and specificity to drastically improve the effectiveness of vision screening worldwide.

97% sensitivity yields a high level of pass assurance, while 87% specificity reduces the cost and burden of over-referrals. blinq may be reimbursable, contact your representative for more information.

 
 
 

Empirical Results

  • Definitive “pass” and “refer” output for amblyopia, including refractive amblyopia, micro strabismus, and strabismus

  • Eliminates interpretation of confounding data

 
EmpiricalResults.png
 
 
 
 
ModernApplictions.png

Modern Application

  • blinq is designed to meet today’s screening needs

  • Encrypted data enables screening programs to remain HIPAA compliant and secure patient privacy

  • Intuitive data management applications on the device and tandem web-based tools

  • Wirelessly “push” patient list to blinq and “pull” screening results, eliminating the paper-trail and floating USB sticks